| Literature DB >> 30639323 |
Justyna A Karolak1, Marie Vincent2, Gail Deutsch3, Tomasz Gambin4, Benjamin Cogné2, Olivier Pichon5, Francesco Vetrini6, Heather C Mefford7, Jennifer N Dines8, Katie Golden-Grant9, Katrina Dipple10, Amanda S Freed8, Kathleen A Leppig11, Megan Dishop12, David Mowat13, Bruce Bennetts14, Andrew J Gifford15, Martin A Weber16, Anna F Lee17, Cornelius F Boerkoel18, Tina M Bartell19, Catherine Ward-Melver20, Thomas Besnard2, Florence Petit21, Iben Bache22, Zeynep Tümer23, Marie Denis-Musquer24, Madeleine Joubert24, Jelena Martinovic25, Claire Bénéteau2, Arnaud Molin26, Dominique Carles27, Gwenaelle André27, Eric Bieth28, Nicolas Chassaing28, Louise Devisme29, Lara Chalabreysse30, Laurent Pasquier31, Véronique Secq32, Massimiliano Don33, Maria Orsaria34, Chantal Missirian35, Jérémie Mortreux35, Damien Sanlaville36, Linda Pons36, Sébastien Küry2, Stéphane Bézieau2, Jean-Michel Liet37, Nicolas Joram37, Tiphaine Bihouée38, Daryl A Scott39, Chester W Brown40, Fernando Scaglia41, Anne Chun-Hui Tsai42, Dorothy K Grange43, John A Phillips44, Jean P Pfotenhauer44, Shalini N Jhangiani45, Claudia G Gonzaga-Jauregui46, Wendy K Chung47, Galen M Schauer48, Mark H Lipson19, Catherine L Mercer49, Arie van Haeringen50, Qian Liu51, Edwina Popek52, Zeynep H Coban Akdemir51, James R Lupski53, Przemyslaw Szafranski51, Bertrand Isidor2, Cedric Le Caignec54, Paweł Stankiewicz55.
Abstract
Primary defects in lung branching morphogenesis, resulting in neonatal lethal pulmonary hypoplasias, are incompletely understood. To elucidate the pathogenetics of human lung development, we studied a unique collection of samples obtained from deceased individuals with clinically and histopathologically diagnosed interstitial neonatal lung disorders: acinar dysplasia (n = 14), congenital alveolar dysplasia (n = 2), and other lethal lung hypoplasias (n = 10). We identified rare heterozygous copy-number variant deletions or single-nucleotide variants (SNVs) involving TBX4 (n = 8 and n = 2, respectively) or FGF10 (n = 2 and n = 2, respectively) in 16/26 (61%) individuals. In addition to TBX4, the overlapping ∼2 Mb recurrent and nonrecurrent deletions at 17q23.1q23.2 identified in seven individuals with lung hypoplasia also remove a lung-specific enhancer region. Individuals with coding variants involving either TBX4 or FGF10 also harbored at least one non-coding SNV in the predicted lung-specific enhancer region, which was absent in 13 control individuals with the overlapping deletions but without any structural lung anomalies. The occurrence of rare coding variants involving TBX4 or FGF10 with the putative hypomorphic non-coding SNVs implies a complex compound inheritance of these pulmonary hypoplasias. Moreover, they support the importance of TBX4-FGF10-FGFR2 epithelial-mesenchymal signaling in human lung organogenesis and help to explain the histopathological continuum observed in these rare lethal developmental disorders of the lung.Entities:
Keywords: 17q23.1q23.2 recurrent deletion; 5p12 deletion; T-box transcription factor 4; aplasia of lacrimal and salivary glands; fibroblast growth factor 10; lacrimoauriculodentodigital (LAAD) syndrome; lung hypoplasia; neonatal lung disease
Mesh:
Substances:
Year: 2019 PMID: 30639323 PMCID: PMC6369446 DOI: 10.1016/j.ajhg.2018.12.010
Source DB: PubMed Journal: Am J Hum Genet ISSN: 0002-9297 Impact factor: 11.025